Geerts, H., Wikswo, J., van der Graaf, P. H., Bai, J. P., Gaiteri, C., Bennett, D., … & Pelleymounter, M. (2020). Quantitative systems pharmacology for neuroscience drug discovery and development: current status, opportunities, and challenges. CPT: pharmacometrics & systems pharmacology, 9(1), 5-20.
Keywords: neurophenomenology, neurofeedback, multiscale neural dynamics, downward causation, voluntary action Citation: Bagdasaryan J and Le Van Quyen M (2013) Experiencing your brain: neurofeedback as a new bridge between neuroscience and phenomenology. Front. Hum. Neurosci. 7:680. doi: 10.3389/fnhum.2013.00680
No “Aha” Moments Here… Last week, the following research headline ran in EurekAlert!, a science news outlet produced by the American Association for the Advancement of Science (AAAS): “Parents of children with complex medical conditions more likely to have mental health issues” You don’t say. Unfortunately, obvious research headers like this one are not uncommon. They …
We desperately act in ways that are less and less driven by our real values, and that are increasingly driven by our need to be valued. Maybe that anxious, phrenetic energy undermines our ability to stop, reflect, and think. Maybe the best way that we can do to functionally manage is to seek refuge in the comfort of categorical simplicity and binaries: of dramatic hero-villain narratives.